Cargando…

A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing

Clinical evidence indicates that the microenvironment in malignant pleural effusion (MPE) is immunologically cold, which impairs tumour immunosurveillance and antitumor immune response to immune checkpoint blockade (ICB). In a recent issue of Nature Nanotechnology, Liu et al. demonstrate a new nanot...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Zhao, Dawen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926894/
https://www.ncbi.nlm.nih.gov/pubmed/35297203
http://dx.doi.org/10.1002/ctm2.774
_version_ 1784670333370892288
author Liu, Yang
Zhao, Dawen
author_facet Liu, Yang
Zhao, Dawen
author_sort Liu, Yang
collection PubMed
description Clinical evidence indicates that the microenvironment in malignant pleural effusion (MPE) is immunologically cold, which impairs tumour immunosurveillance and antitumor immune response to immune checkpoint blockade (ICB). In a recent issue of Nature Nanotechnology, Liu et al. demonstrate a new nanotechnological approach to effectively mitigate the immune cold MPE and provide insights into its mechanism of action through single‐cell RNA‐sequencing.
format Online
Article
Text
id pubmed-8926894
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89268942022-03-24 A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing Liu, Yang Zhao, Dawen Clin Transl Med Editorial Clinical evidence indicates that the microenvironment in malignant pleural effusion (MPE) is immunologically cold, which impairs tumour immunosurveillance and antitumor immune response to immune checkpoint blockade (ICB). In a recent issue of Nature Nanotechnology, Liu et al. demonstrate a new nanotechnological approach to effectively mitigate the immune cold MPE and provide insights into its mechanism of action through single‐cell RNA‐sequencing. John Wiley and Sons Inc. 2022-03-16 /pmc/articles/PMC8926894/ /pubmed/35297203 http://dx.doi.org/10.1002/ctm2.774 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Liu, Yang
Zhao, Dawen
A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
title A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
title_full A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
title_fullStr A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
title_full_unstemmed A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
title_short A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
title_sort novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: insights into its mechanism of action through single‐cell rna‐sequencing
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926894/
https://www.ncbi.nlm.nih.gov/pubmed/35297203
http://dx.doi.org/10.1002/ctm2.774
work_keys_str_mv AT liuyang anovelnanoimmunotherapeuticremodelstheimmunelandscapeofmalignantpleuraleffusioninsightsintoitsmechanismofactionthroughsinglecellrnasequencing
AT zhaodawen anovelnanoimmunotherapeuticremodelstheimmunelandscapeofmalignantpleuraleffusioninsightsintoitsmechanismofactionthroughsinglecellrnasequencing
AT liuyang novelnanoimmunotherapeuticremodelstheimmunelandscapeofmalignantpleuraleffusioninsightsintoitsmechanismofactionthroughsinglecellrnasequencing
AT zhaodawen novelnanoimmunotherapeuticremodelstheimmunelandscapeofmalignantpleuraleffusioninsightsintoitsmechanismofactionthroughsinglecellrnasequencing